Alexion Pharmaceuticals, Inc.
METHODS OF TREATING MYOINTIMAL PROLIFERATION
Last updated:
Abstract:
The present invention provides a method of treating myointimal proliferation by administering a recombinant human soluble ectonucleotide pyrophosphatase phosphodiesterase (hsNPP1), active fragment or fusion protein thereof.
Status:
Application
Type:
Utility
Filling date:
15 Jun 2017
Issue date:
1 Oct 2020